相关实验视频
Updated: Jul 26, 2025

08:04
Murine Fetal Echocardiography
Published on: February 15, 2013
17.4K
怀孕期间使用塞特拉林的胎儿心脏安全性
Line Kolding1,2, Jakob N Henriksen2,3, Lars Henning Pedersen1,2,4
1Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
Expert opinion on drug safety
|June 19, 2023
概括
怀孕期间使用塞特拉林与隔膜心脏缺陷有关,但不是严重的发育不良. 虽然存在混因素,但这种关联不应该阻止对母亲抑郁症的必要治疗.
科学领域:
- 产科和妇科 产科和妇科
- 新生儿心脏病学 新生儿心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 怀孕期间常见的抗抑郁药Sertraline对胎儿心脏的安全性仍然是争论的主题.
- 塞特拉林对胎儿心脏发育的潜在影响,包括形和微妙变化,理论上是可能的,但由于固有的错误,研究是具有挑战性的.
研究的目的:
- 在怀孕期间批判性地评估塞特拉林的胎儿心脏安全概况.
- 综合当前关于塞特拉林对胎儿心脏发育和功能影响的证据.
主要方法:
- 进行了全面的文献审查,包括在Medline索引的研究,直到2022年11月.
- 没有对出版时间或语言的限制,以确保彻底分析.
主要成果:
- 塞特拉林与胎儿隔膜心脏形有关,但与更严重的心脏形无关.
- 观察到的关联可能是因果关系或受到系统错误的影响,例如通过指示混.
- 关于胎儿心脏功能的现有数据令人放心,并且致病性研究没有表明长期心脏风险.
结论:
- 塞特拉林与隔膜心脏形之间的关联不应排除其用于适合于治疗母亲抑郁症的使用.
- 需要进一步研究后代的长期心脏影响以及怀孕期间药物相互作用的影响.
相关概念视频
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
211
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
211
Adrenergic Antagonists: ɑ and β-Receptor Blockers
524
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
524
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.5K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.5K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
354
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
354
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
453
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
453

